BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33749820)

  • 1. Expression of miRNA in obesity and insulin resistance: a review.
    Estrella Ibarra P; García-Solís P; Solís-Sáinz JC; Cruz-Hernández A
    Endokrynol Pol; 2021; 72(1):73-80. PubMed ID: 33749820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA regulatory networks in human adipose tissue and obesity.
    Arner P; Kulyté A
    Nat Rev Endocrinol; 2015 May; 11(5):276-88. PubMed ID: 25732520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice.
    Zhao E; Keller MP; Rabaglia ME; Oler AT; Stapleton DS; Schueler KL; Neto EC; Moon JY; Wang P; Wang IM; Lum PY; Ivanovska I; Cleary M; Greenawalt D; Tsang J; Choi YJ; Kleinhanz R; Shang J; Zhou YP; Howard AD; Zhang BB; Kendziorski C; Thornberry NA; Yandell BS; Schadt EE; Attie AD
    Mamm Genome; 2009 Aug; 20(8):476-85. PubMed ID: 19727952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer.
    Heyn GS; Corrêa LH; Magalhães KG
    Front Endocrinol (Lausanne); 2020; 11():563816. PubMed ID: 33123088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance.
    Liu T; Sun YC; Cheng P; Shao HG
    Biochem Biophys Res Commun; 2019 Jul; 515(2):352-358. PubMed ID: 31153636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of microRNAs in Type 2 diabetes.
    Ferland-McCollough D; Ozanne SE; Siddle K; Willis AE; Bushell M
    Biochem Soc Trans; 2010 Dec; 38(6):1565-70. PubMed ID: 21118127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play A Role?
    Cirillo F; Catellani C; Sartori C; Lazzeroni P; Amarri S; Street ME
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in insulin resistance and obesity.
    Williams MD; Mitchell GM
    Exp Diabetes Res; 2012; 2012():484696. PubMed ID: 22851965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs in Human Adipose Tissue Physiology and Dysfunction.
    Kurylowicz A
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.
    Deiuliis JA
    Int J Obes (Lond); 2016 Jan; 40(1):88-101. PubMed ID: 26311337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into miRNAs related with glucometabolic disorder.
    Zhang BH; Shen CA; Zhu BW; An HY; Zheng B; Xu SB; Sun JC; Sun PC; Zhang W; Wang J; Liu JY; Fan YQ
    Biomed Pharmacother; 2019 Mar; 111():657-665. PubMed ID: 30611990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs Caught Up in Metabolic Organ Crosstalk to Combat Obesity.
    Ntambi JM
    EBioMedicine; 2016 Mar; 5():10-1. PubMed ID: 27077099
    [No Abstract]   [Full Text] [Related]  

  • 13. Adipose-derived exosomes: A novel adipokine in obesity-associated diabetes.
    Zhang B; Yang Y; Xiang L; Zhao Z; Ye R
    J Cell Physiol; 2019 Aug; 234(10):16692-16702. PubMed ID: 30807657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets.
    Lorente-Cebrián S; González-Muniesa P; Milagro FI; Martínez JA
    Clin Sci (Lond); 2019 Jan; 133(1):23-40. PubMed ID: 30606812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Adipose Tissue microRNAs in the Onset of Metabolic Diseases and Implications in the Context of the DOHaD.
    Kappeler L
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of the role of microRNAs from adipose-derived extracellular vesicles in obesity.
    Zhao L; Yang H; Li X; Zhao Y
    Biochem Soc Trans; 2022 Feb; 50(1):447-457. PubMed ID: 34940800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of miRNAs to the adipose organ for metabolic health.
    Kornmueller K; Amri EZ; Scheideler M; Prassl R
    Adv Drug Deliv Rev; 2022 Feb; 181():114110. PubMed ID: 34995679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral Adipose Tissue E2F1-miRNA206/210 Pathway Associates with Type 2 Diabetes in Humans with Extreme Obesity.
    Maixner N; Haim Y; Blüher M; Chalifa-Caspi V; Veksler-Lublinsky I; Makarenkov N; Yoel U; Bashan N; Liberty IF; Kukeev I; Dukhno O; Levy D; Rudich A
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231008
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNAs in adipose tissue: their role in adipogenesis and obesity.
    Hilton C; Neville MJ; Karpe F
    Int J Obes (Lond); 2013 Mar; 37(3):325-32. PubMed ID: 22531086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive functional screening of miRNAs involved in fat cell insulin sensitivity among women.
    Dahlman I; Belarbi Y; Laurencikiene J; Pettersson AM; Arner P; Kulyté A
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E482-E494. PubMed ID: 28270439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.